| Literature DB >> 33061787 |
Ambele M Mwandigha1, Doreen Kamori1, Upendo O Kibwana1, Salim Masoud1, Joel Manyahi1, Mtebe Majigo1.
Abstract
BACKGROUND: Infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) are increasing worldwide. Evidence indicates that fecal carriage of ESBL-E in pregnancy predisposes women to potential life-threatening urinary tract infections and subsequently increasing the risk of neonatal infections. There is limited data regarding fecal carriage of ESBL-E and associated factors among pregnant women in Tanzania. We aimed to address the gap by determining the proportion of pregnant women with ESBL-E fecal carriage and identify the related factors.Entities:
Keywords: Antimicrobial resistance; Enterobacteriaceae; Extended-spectrum beta-lactamase; Fecal carriage; Pregnancy
Year: 2020 PMID: 33061787 PMCID: PMC7545914 DOI: 10.1186/s41182-020-00271-2
Source DB: PubMed Journal: Trop Med Health ISSN: 1348-8945
Distribution of socio-demographic, clinical, and hygienic variables among pregnant women (N = 182)
| Variable | Total number | Percentage (%) |
|---|---|---|
| 18–25 | 50 | 27.5 |
| 26–35 | 107 | 58.8 |
| 36+ | 25 | 13.7 |
| 37–39 | 121 | 66.5 |
| 40–42 | 57 | 31.3 |
| 43–45 | 4 | 2.2 |
| 0–1 | 73 | 40.1 |
| 2 | 53 | 29.1 |
| 3+ | 56 | 30.8 |
| Low | 80 | 44.0 |
| High | 102 | 56.0 |
| Positive | 9 | 5.0 |
| Negative | 173 | 95.0 |
| Yes | 95 | 52.2 |
| No | 87 | 47.8 |
| Flush | 154 | 84.6 |
| Hole | 28 | 15.4 |
| No | 46 | 25.3 |
| Yes | 136 | 74.7 |
| Yes | 159 | 87.4 |
| No | 23 | 12.6 |
| Yes | 156 | 85.7 |
| No | 26 | 14.3 |
| Yes | 113 | 62.1 |
| No | 69 | 37.9 |
Fecal carriage of ESBL-E among pregnant women by social-demographic, clinical factors, and hygienic factors
| Variable | Total number | Fecal carriage, | |
|---|---|---|---|
| Overall | 182 | 117 (64.3) | |
| 0.06 | |||
| 18–25 | 50 | 39 (78.0) | |
| 26–35 | 107 | 63 (58.9) | |
| 35+ | 25 | 15 (60.0) | |
| 0.69 | |||
| 37–39 | 121 | 75 (62.0) | |
| 40–42 | 57 | 39 (68.4) | |
| 43–45 | 4 | 3 (75.0) | |
| 0.26 | |||
| 0–1 | 73 | 50 (68.5) | |
| 2 | 53 | 36 (67.9) | |
| 3+ | 56 | 31 (55.4) | |
| Low | 80 | 62 (77.5) | |
| High | 102 | 55 (53.9) | |
| 0.16 | |||
| Positive | 9 | 8 (88.9) | |
| Negative | 173 | 109 (63.0) | |
| Yes | 95 | 72 (75.8) | |
| No | 87 | 45 (51.7) | |
| 1.00 | |||
| Flush | 154 | 99 (64.3) | |
| Hole | 28 | 18 (64.3) | |
| No | 46 | 22 (47.8) | |
| Yes | 136 | 95 (69.9) | |
| 0.17 | |||
| Yes | 159 | 99 (62.3) | |
| No | 23 | 18 (78.3) | |
| Yes | 156 | 95 (60.9) | |
| No | 26 | 22 (84.6) | |
| 0.27 | |||
| Yes | 113 | 69 (61.1) | |
| No | 69 | 48 (69.6) |
In bold p value of less than 0.05 that indicates statistically significant association (Fisher’s exact test)
Socio-demographic, clinical, and hygienic factors associated with ESBL-E fecal carriage by bivariate analysis
| Variable | Total number | Positive, | cOR | 95% CI | |
|---|---|---|---|---|---|
| 182 | 117 (64.3) | 0.95 | 0.89–1.00 | 0.07 | |
| Low | 80 | 62 (77.5) | 2.94 | 1.53–5.66 | |
| High | 102 | 55 (53.9) | 1 | ||
| Positive | 9 | 8 (88.9) | 4.70 | 0.57–38.42 | 0.15 |
| Negative | 173 | 109 (63.0) | Ref | ||
| Yes | 95 | 72 (75.8) | 2.92 | 1.56–5.49 | |
| No | 87 | 45 (51.7) | Ref | ||
| No | 46 | 22 (47.8) | Ref | ||
| Yes | 136 | 95 (69.9) | 2.53 | 1.27–5.01 | |
| Yes | 159 | 99 (62.3) | Ref | ||
| No | 23 | 18 (78.3) | 2.18 | 0.77–6.18 | 0.14 |
| Yes | 156 | 95 (60.9) | Ref | ||
| No | 26 | 22 (84.6) | 3.53 | 1.16–10.74 | |
cOR crude odds ratio, Ref reference
Multivariate logistic regression for the factors independently associated with ESBL-E fecal carriage
| Variable | ESBL-E fecal carriage, | cOR | 95% CI | aOR | 95% CI | ||
|---|---|---|---|---|---|---|---|
| Low | 62 (77.5) | 2.94 | 1.53–5.66 | 2.19 | 1.08–4.43 | ||
| High | 55 (53.9) | Ref | Ref | ||||
| Yes | 72 (75.8) | 2.92 | 1.56–5.49 | 3.11 | 1.59–6.01 | ||
| No | 45 (51.7) | Ref | Ref | ||||
| No | 22 (47.8) | Ref | Ref | ||||
| Yes | 95 (69.9) | 2.53 | 1.27–5.01 | 2.39 | 1.10–5.21 | ||
| Yes | 95 (60.9) | Ref | Ref | ||||
| No | 22 (84.6) | 3.53 | 1.16–10.74 | 2.69 | 0.83–8.72 | 0.10 | |
cOR crude odds ratio, aOR adjusted odds ratio, Ref reference
Fig. 1Proportion of ESBL-E species isolated from pregnant women. The figure illustrates the distribution of specific ESBL-E isolates obtained from 182 pregnant women at Muhimbili National Hospital
Antimicrobial resistance patterns among ESBL-E isolates
| ESBL-E isolates | Gentamicin, | Aztreonam, | Sulphamethoxazole-trimethoprim, | Meropenem, | Ciprofloxacin, |
|---|---|---|---|---|---|
| 1 (25.0) | 89 (85.6) | 79 (76.0) | 31 (29.8) | 24 (23.1) | |
| 4 (36.4) | 10 (90.9) | 7 (63.6) | 3 (27.3) | 1 (9.1) | |
| 18 (17.3) | 3 (75.0) | 3 (75.0) | 3 (75.0) | 1 (25.0) | |
| 0 | 1 (50) | 2 (100.0) | 0 | 0 | |
| 0 | 2 (100.0) | 1 (50) | 0 | 0 |